Literature DB >> 9792059

Potential impact of Pneumocystis genetic diversity on the molecular detection of the parasite in human host.

E Tamburrini1, P Mencarini, E Visconti, M Zolfo, S Marinaci, D Zinzi, P Margutti, E Ortona, A Siracusano.   

Abstract

Our aim was to evaluate if genetic diversity of Pneumocystis carinii could influence the detection by molecular techniques in bronchoalveolar lavage (BAL) fluids and in non-invasive specimens (induced sputum, oropharyngeal washing and serum/blood). P. carinii is morphologically similar in different hosts although several strains have been identified by biomolecular techniques. Variations of mt-LSU and ITSs sequences could determine a lack of hybridization of some clinical samples and could have diagnostic consequences with loss in sensitivity and specificity of available molecular tests, but at the moment no data support a significant impact of genetic diversity in these sequences on molecular detection of P. carinii for clinical purposes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792059     DOI: 10.1111/j.1574-695X.1998.tb01185.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  4 in total

1.  Molecular Diagnosis of Pneumocystis jirovecii Pneumonia by Use of Oral Wash Samples in Immunocompromised Patients: Usefulness and Importance of the DNA Target.

Authors:  Lidia Goterris; Miguel Angel Mancebo Fernández; Juan Aguilar-Company; Vicenç Falcó; Isabel Ruiz-Camps; M Teresa Martín-Gómez
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

2.  Improved detection of Pneumocystis jirovecii in upper and lower respiratory tract specimens from children with suspected pneumocystis pneumonia using real-time PCR: a prospective study.

Authors:  Catherine M Samuel; Andrew Whitelaw; Craig Corcoran; Brenda Morrow; Nei-Yuan Hsiao; Marco Zampoli; Heather J Zar
Journal:  BMC Infect Dis       Date:  2011-11-28       Impact factor: 3.090

3.  Pneumocystis pneumonia in children - the relevance of chemoprophylaxis in different groups of immunocompromised and immunocompetent paediatric patients.

Authors:  Olga Zajac-Spychała; Ewelina Gowin; Piotr Fichna; Jacek Wysocki; Marta Fichna; Arleta Kowala-Piaskowska; Iwona Mozer-Lisewska; Jerzy Nowak; Danuta Januszkiewicz-Lewandowska
Journal:  Cent Eur J Immunol       Date:  2015-04-22       Impact factor: 2.085

Review 4.  [Rapid diagnostic test for respiratory infections].

Authors:  José María Marimón; José María Navarro-Marí
Journal:  Enferm Infecc Microbiol Clin       Date:  2017-01-03       Impact factor: 1.731

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.